Clovis Oncology Inc ROCE
¿Qué es el ROCE de Clovis Oncology Inc?
El ROCE de Clovis Oncology Inc es 53.64%
¿Cuál es la definición de ROCE?
El retorno sobre el capital empleado (ROCE) es una relación financiera que mide la rentabilidad de una empresa y la eficiencia con la que se utiliza su capital.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de compañías en Sector Health Care en NASDAQ en comparadas con Clovis Oncology Inc
Empresas con roce similar a Clovis Oncology Inc
- Esso tiene ROCE de 52.65%
- Qifu Technology tiene ROCE de 52.71%
- Houston Nat Res tiene ROCE de 52.84%
- VAALCO tiene ROCE de 52.95%
- GrainCorp tiene ROCE de 52.96%
- Backstageplay tiene ROCE de 53.41%
- Clovis Oncology Inc tiene ROCE de 53.64%
- Triterras tiene ROCE de 53.68%
- Triumph tiene ROCE de 53.84%
- Hoist Capital tiene ROCE de 53.93%
- National Research Corp tiene ROCE de 53.99%
- Champion Iron tiene ROCE de 54.04%
- Blue Bird Corp tiene ROCE de 54.52%